Advertisement

Public reporting on cardiac electrophysiology procedures and outcomes: where are we now and where are we headed?

  • Samuel M. Kim
  • Jim W. CheungEmail author
Article

Abstract

Over the years, public reporting of patient outcomes has been promoted as a means to improve healthcare quality. More recently, in response to dramatic rises in healthcare costs, the Medicare Access and CHIP Reauthorization Act (MACRA) of 2015 was implemented in an effort to link quality with reimbursement. As part of a value-based model, public reporting of procedural outcomes has been incorporated into this initiative. Outcomes measures that have been introduced in cardiology include heart failure readmission and post-myocardial infarction medication prescription. Public reporting of these data has led not only to positive changes but also to unintended negative consequences. The limited number of existing registries and lack of clear consensus on quality metrics have posed challenges for quality and value assessment in cardiac electrophysiology. After learning from the lessons of existing models of public reporting, physicians, professional societies, stakeholders, and patients will need to collaborate to develop a health care model that can improve outcomes and reduce waste.

Keywords

Electrophysiology Outcome and performance measures Public reporting 

Notes

Compliance with ethical standards

Conflict of interest

Dr. Jim W. Cheung has received consulting fees from Biosense Webster, speaker honoraria from Zoll, research grant support from Biotronik, and fellowship grant support from Biotronik, Boston Scientific, Medtronic, and St. Jude Medical. Dr. Kim has no relevant disclosures.

Ethical approval on research involving human participants and/or animals

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

Not applicable.

References

  1. 1.
    Topol EJ, Califf RM. Scorecard cardiovascular medicine. Its impact and future directions. Ann Intern Med. 1994;120(1):65–70.CrossRefGoogle Scholar
  2. 2.
    Potter BJ, Yeh RW, Pinto DS. Public reporting of PCI outcomes: for better or for worse. Curr Cardiol Rep. 2014;16(7):500.CrossRefGoogle Scholar
  3. 3.
    Hartman M, Martin AB, Espinosa N, Catlin A, The National Health Expenditure Accounts Team. National health care spending in 2016: spending and enrollment growth slow after initial coverage expansions. Health Aff (Millwood). 2018;37(1):150–60.CrossRefGoogle Scholar
  4. 4.
    Hussey PS, Liu JL, White C. The Medicare access and CHIP reauthorization act: effects on Medicare payment policy and spending. Health Aff (Millwood). 2017;36(4):697–705.CrossRefGoogle Scholar
  5. 5.
    Findlay S. Health policy brief: implementing MACRA. Health Aff (Millwood) 2017.Google Scholar
  6. 6.
    Casalino LP. The Medicare access and CHIP reauthorization act and the corporate transformation of American medicine. Health Aff (Millwood). 2017;36(5):865–9.CrossRefGoogle Scholar
  7. 7.
  8. 8.
    Wasfy JH, Borden WB, Secemsky EA, McCabe JM, Yeh RW. Public reporting in cardiovascular medicine: accountability, unintended consequences, and promise for improvement. Circulation. 2015;131(17):1518–27.CrossRefGoogle Scholar
  9. 9.
    Ray JC, Kusumoto F. The transition to value-based care. J Interv Card Electrophysiol. 2016;47(1):61–8.CrossRefGoogle Scholar
  10. 10.
    Anhang Price R, Elliott MN, Zaslavsky AM, Hays RD, Lehrman WG, Rybowski L, et al. Examining the role of patient experience surveys in measuring health care quality. Med Care Res Rev. 2014;71(5):522–54.CrossRefGoogle Scholar
  11. 11.
    Fonarow GC, Konstam MA, Yancy CW. The hospital readmission reduction program is associated with fewer readmissions, more deaths: time to reconsider. J Am Coll Cardiol. 2017;70(15):1931–4.CrossRefGoogle Scholar
  12. 12.
    Lilford RJ, Brown CA, Nicholl J. Use of process measures to monitor the quality of clinical practice. BMJ. 2007;335(7621):648–50.CrossRefGoogle Scholar
  13. 13.
    Hannan EL, Cozzens K, King SB 3rd, Walford G, Shah NR. The New York state cardiac registries: history, contributions, limitations, and lessons for future efforts to assess and publicly report healthcare outcomes. J Am Coll Cardiol. 2012;59(25):2309–16.CrossRefGoogle Scholar
  14. 14.
    Dehmer GJ, Jennings J, Madden RA, Malenka DJ, Masoudi FA, McKay CR, et al. The national cardiovascular data registry voluntary public reporting program: an interim report from the NCDR public reporting advisory group. J Am Coll Cardiol. 2016;67(2):205–15.CrossRefGoogle Scholar
  15. 15.
    Miller G, Hughes-Cromwick P, Roehrig C. National spending on cardiovascular disease, 1996-2008. J Am Coll Cardiol. 2011;58(19):2017–9.CrossRefGoogle Scholar
  16. 16.
    Friedman DJ, Al-Khatib SM. Measuring quality in electrophysiology. J Interv Card Electrophysiol. 2016;47(1):5–10.CrossRefGoogle Scholar
  17. 17.
    Kusumoto FM, Hao SC, Slotwiner DJ, Cheung JW, Hsu JC, Kowalski M, et al. Arrhythmia care in a value-based environment: past, present, and future: developed and endorsed by the heart rhythm society (HRS). Heart Rhythm. 2018;15(2):e5–e15.CrossRefGoogle Scholar
  18. 18.
    Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352(3):225–37.CrossRefGoogle Scholar
  19. 19.
  20. 20.
  21. 21.
    Fontenla A, Garcia-Fernandez J, Ibanez JL, Spanish Catheter Ablation Registry collaborators. Spanish catheter ablation registry. 16th official report of the Spanish society of cardiology working group on electrophysiology and arrhythmias (2016). Rev Esp Cardiol (Engl Ed). 2017;70(11):971–82.CrossRefGoogle Scholar
  22. 22.
    Krantz MJ, Ambardekar AV, Kaltenbach L, Hernandez AF, Heidenreich PA, Fonarow GC. Get With the Guidelines Steering Committee and Hospitals. Patterns and predictors of evidence-based medication continuation among hospitalized heart failure patients (from Get with the guidelines-heart failure). Am J Cardiol. 2011;107(12):1818–23.CrossRefGoogle Scholar
  23. 23.
    Dehmer GJ, Drozda JP Jr, Brindis RG, Masoudi FA, Rumsfeld JS, Slattery LE, et al. Public reporting of clinical quality data: an update for cardiovascular specialists. J Am Coll Cardiol. 2014;63(13):1239–45.CrossRefGoogle Scholar
  24. 24.
    Campanella P, Vukovic V, Parente P, Sulejmani A, Ricciardi W, Specchia ML. The impact of public reporting on clinical outcomes: a systematic review and meta-analysis. BMC Health Serv Res. 2016;16:296.CrossRefGoogle Scholar
  25. 25.
    Cox ZL, Lai P, Lewis CM, Lenihan DJ. Centers for Medicare and Medicaid services’ readmission reports inaccurately describe an institution’s decompensated heart failure admissions. Clin Cardiol. 2017;40(9):620–5.CrossRefGoogle Scholar
  26. 26.
    Gupta A, Allen LA, Bhatt DL, Cox M, DeVore AD, Heidenreich PA, et al. Association of the hospital readmissions reduction program implementation with readmission and mortality outcomes in heart failure. JAMA Cardiol. 2018;3(1):44–53.CrossRefGoogle Scholar
  27. 27.
    Green J, Wintfeld N. Report cards on cardiac surgeons. Assessing New York State’s approach. N Engl J Med. 1995;332(18):1229–32.CrossRefGoogle Scholar
  28. 28.
    Joynt KE, Blumenthal DM, Orav EJ, Resnic FS, Jha AK. Association of public reporting for percutaneous coronary intervention with utilization and outcomes among medicare beneficiaries with acute myocardial infarction. JAMA. 2012;308(14):1460–8.CrossRefGoogle Scholar
  29. 29.
    Salerno AM, Horwitz LI, Kwon JY, Herrin J, Grady JN, Lin Z, et al. Trends in readmission rates for safety net hospitals and non-safety net hospitals in the era of the US hospital readmission reduction program: a retrospective time series analysis using Medicare administrative claims data from 2008 to 2015. BMJ Open. 2017;7:e016149.CrossRefGoogle Scholar
  30. 30.
    Pokorney SD, Miller AL, Chen AY, Thomas L, Fonarow GC, de Lemos JA, et al. Implantable cardioverter-defibrillator use among Medicare patients with low ejection fraction after acute myocardial infarction. JAMA. 2015;313(24):2433–40.CrossRefGoogle Scholar
  31. 31.
    Matlock DD, Peterson PN, Wang Y, Curtis JP, Reynolds MR, Varosy PD, et al. Variation in use of dual-chamber implantable cardioverter-defibrillators: results from the national cardiovascular data registry. Arch Intern Med. 2012;172(8):634,41.Google Scholar
  32. 32.
    Friedman DJ, Parzynski CS, Varosy PD, Prutkin JM, Patton KK, Mithani A, et al. Trends and in-hospital outcomes associated with adoption of the subcutaneous implantable cardioverter defibrillator in the United States. JAMA Cardiol. 2016;1(8):900–11.CrossRefGoogle Scholar
  33. 33.
    Xian Y, Hammill BG, Curtis LH. Data sources for heart failure comparative effectiveness research. Heart Fail Clin. 2013;9(1):1–13.CrossRefGoogle Scholar
  34. 34.
    Dunlay SM, Alexander KP, Melloni C, Kraschnewski JL, Liang L, Gibler WB, et al. Medical records and quality care in acute coronary syndromes. JAMA. 2008;168(15):1692–8.Google Scholar
  35. 35.
    Lyu H, Cooper M, Patel K, Daniel M, Makary MA. Prevalence and data transparency of National Clinical Registries in the United States. J Healthc Qual. 2016;38(4):223–34.CrossRefGoogle Scholar
  36. 36.
    Austin C, Kusumoto F. The application of big data in medicine: current implications and future directions. J Interv Card Electrophysiol. 2016;47(1):51–9.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Division of Cardiology, Department of MedicineNewYork Presbyterian Hospital—Weill Cornell MedicineNew YorkUSA

Personalised recommendations